humanitarian

Human medicines European public assessment report (EPAR): Spectrila, asparaginase, Date of authorisation: 14/01/2016, Revision: 7, Status: Authorised

Human medicines European public assessment report (EPAR): Ahzantive, aflibercept, Date of authorisation: 13/01/2025, Revision: 6, Status: Authorised

Reported by EMA What Is New Oct 19, 2026 · 15:30 UTC

Read the complete report at EMA What Is New ↗

Verification notice

IntelMap indexes open-source reporting. This page identifies what a source reported; it does not independently confirm the claim.

INCIDENT FUSION

12 reports · 2 sources

EMA What Is NewHuman medicines European public assessment report (EPAR): Spectrila, asparaginase, Date of authorisation: 14/01/2016, Revision: 7, Status: Authorised15:30 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Spectrila, asparaginase, Date of authorisation: 14/01/2016, Revision: 7, Status: Authorised15:30 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Capvaxive, pneumococcal polysaccharide conjugate vaccine (21-valent), Date of authorisation: 24/03/2025, Revision: 5, Sta…15:25 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Capvaxive, pneumococcal polysaccharide conjugate vaccine (21-valent), Date of authorisation: 24/03/2025, Revision: 5, Sta…15:25 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): mNexspike, COVID-19 mRNA vaccine, Date of authorisation: 12/02/2026, Revision: 1, Status: Authorised15:10 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): mNexspike, COVID-19 mRNA vaccine, Date of authorisation: 12/02/2026, Revision: 1, Status: Authorised15:10 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Orphacol, cholic acid, Date of authorisation: 12/09/2013, Revision: 20, Status: Authorised15:05 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Orphacol, cholic acid, Date of authorisation: 12/09/2013, Revision: 20, Status: Authorised15:05 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Delstrigo, doravirine,lamivudine,tenofovir disoproxil, Date of authorisation: 22/11/2018, Revision: 15, Status: Authorised14:56 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Delstrigo, doravirine,lamivudine,tenofovir disoproxil, Date of authorisation: 22/11/2018, Revision: 15, Status: Authorised14:56 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Pifeltro, doravirine, Date of authorisation: 22/11/2018, Revision: 12, Status: Authorised14:50 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Pifeltro, doravirine, Date of authorisation: 22/11/2018, Revision: 12, Status: Authorised14:50 UTC

INCIDENT EVOLUTION

2 recorded states

Oct 19 · 16:26 UTC

Signal first indexedP2 · 99% quality · 2 sources

Oct 19 · 17:08 UTC

Source details updatedP2 · 99% quality · 2 sources

Explore this day in the archive →